• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD NEXIVA; PERIPHERAL IV CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD NEXIVA; PERIPHERAL IV CATHETER Back to Search Results
Catalog Number UNKNOWN
Device Problem Break (1069)
Patient Problem Foreign Body Embolism (4439)
Event Date 12/09/2023
Event Type  Injury  
Event Description
It was reported that bd nexiva, catheter broke and remained in the patient's limb.The following information was provided by the initial reporter: the nurse reports that on december 9, a nexiva 20g catheter was removed due to the presence of phlebitis.There is no report of difficulty in removing the device, but the patient persists with signs of phlebitis at the site of removal of the pivc, in addition to a fever, which is why they request a doppler ultrasound where a foreign body is evident in the area where the removal was performed and according to the report a thrombus is also evident, which is why it is necessary to schedule the removal of the foreign body surgically.The nurse will make an institutional report and will contact bd to inform about the event.Additional information received on 18.Dec.2023: what is the amount affected? a: one (1).What medication was being administered? a: furosemide.Could you provide us with the patient's info? could you please settle any patient impact during or after the surgical procedure to remove the foreign body? a: for now the verbal report of the nurse reporting the adverse event is that the procedure could be carried out without complications.Could you confirm the date the event occurred? a: the event occurred on december 9, was notified via phone call on december 14 and the patient was subjected to the surgical procedure on december 15.
 
Manufacturer Narrative
H.3.A device evaluation and/or device history review is anticipated but is not complete.Upon completion a supplemental report will be filed.E1.Address information was not provided, therefore, xx was used as a place holder.
 
Manufacturer Narrative
Investigation summary: as no physical sample, picture sample, or lot number was provided for evaluation by our quality engineer team, a complete investigation could not be performed.Based on the limited investigation results, a root cause for the reported incident could not be determined.Should you again experience any problems with our product we would appreciate the opportunity to conduct a thorough analysis.
 
Event Description
No additional information.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD NEXIVA
Type of Device
PERIPHERAL IV CATHETER
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer (Section G)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer Contact
helen cox (mdr)
75 north fairway drive
vernon hills, IL 60061
8473935694
MDR Report Key18489939
MDR Text Key332602726
Report Number9610847-2023-00369
Device Sequence Number1
Product Code FOZ
UDI-Device Identifier30382903835363
UDI-Public(01)30382903835363
Combination Product (y/n)N
Reporter Country CodeAR
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 02/27/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNKNOWN
Device Lot NumberUNKNOWN
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/14/2023
Initial Date FDA Received01/10/2024
Supplement Dates Manufacturer Received02/27/2024
Supplement Dates FDA Received02/27/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-